Kymera Therapeutics Inc Cash Flow Reinvestment Rate
Kymera Therapeutics Inc cash flow reinvestment rate. Kymera Therapeutics Inc (KYMR) has a Cash Flow Reinvestment Rate of 3.80x as of December 2023, reinvesting $30.58 Million (capex $11.62 Million plus investments $18.95 Million) from operating cash flow of $8.04 Million. Explore Kymera Therapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Kymera Therapeutics Inc (2019–2020)
Cash flow reinvestment rate of Kymera Therapeutics Inc from 2019 to 2020. Historical reinvestment intensity for Kymera Therapeutics Inc across 2 annual periods. Explore Kymera Therapeutics Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Kymera Therapeutics Inc Cash Flow Reinvestment Rate by Year (2019–2020)
Kymera Therapeutics Inc cash flow reinvestment rate by year from 2019 to 2020. Year-by-year capital reinvestment analysis for Kymera Therapeutics Inc. For the full cash flow conversion analysis, see Kymera Therapeutics Inc operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 4.90x | $431.68 Million | $88.13 Million | $9.10 Million | ▲ +432.0% |
| 2019 | 0.92x | $16.49 Million | $17.91 Million | $532.00K | — |